DV
Dividend Vision

INTI — Inhibitor Therapeutics Inc

Inhibitor Therapeutics Inc (INTI)

Total return is -99.1% over the past 28.8 years, 1383.9 points behind SPY at 1284.8%. Its deepest 1-year drawdown was 52.4%.

INTI is an equity fund focused on stock investments, with an inception date of 1997. The fund does not currently distribute dividends to shareholders. As a stock-based equity fund, it may appeal to investors seeking capital appreciation rather than current income, though limited publicly available data on its specific strategy, expense ratio, and asset base restrict further characterization of its investment approach.

INTI key facts

Asset type
Stock
Asset class
Equity
Inception date
10/29/1997
Distribution frequency
None
Last close
$0.08
Market cap
$14,151,032
Average volume
0.0
Beta
-0.711
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.02